We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sinclair Pha | LSE:SPH | London | Ordinary Share | GB0033856740 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 31.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/4/2018 12:52 | Thats my worry is that Silhouette is just an also ran. I guess we'll see soon if they get a good licensee deal for it in the US. | red ninja | |
07/4/2018 15:28 | Full page in The Times today (Week-end section page 10) on filler facelifts. Case study using a product called Juvederm Voluma. not Elanse or Perfectha! No mention of Silhouette procedures. These guys MUST get some marketing experts on board. And PDQ. | eggbaconandbubble | |
07/4/2018 06:49 | I agree with what you post Mercer95. IMHO their is a possibility of a takeover also in the future only time will sell. | dealit | |
06/4/2018 22:49 | To be honest I’d already done all my research when I first invested a while back & nothing has changed, I still reckon Sinclair will turn a profit, if not this year then next, facelifts use to be a Hollywood thing, for the rich & famous, it’s now becoming the norm for a lot of women,social media & celebrity culture do all the work for the cosmetic/ aesthetics industry, Sinclair’s threads dissolves after around 2 years, I’m hoping this will eventually lead to Sinclair having a steady stream of re orders.I’m committed here now regardless what the price does up to this months update, I could be completely wrong but I’ve got to be invested somewhere. | mercer95 | |
06/4/2018 16:47 | So, Mercer, what did your 'in-depth' research come up with? Obviously something that makes a punt worthwhile! | eggbaconandbubble | |
06/4/2018 12:40 | For what it’s worth that 20,000 trade that just went through was a buy from me, it’s showing as a sell GLA | mercer95 | |
29/3/2018 14:20 | I’ll call it, I’ve been doing more in-depth research,pass me a banana | mercer95 | |
29/3/2018 14:12 | I was warned by a city friend to beware of calling the low point of any share price as "only chimpanzees pick bottoms" However......... | glynedwards | |
28/3/2018 16:53 | IMHO glynedwards share price will move North when SPH announce the partnership deal in USA. | dealit | |
28/3/2018 16:43 | Thanks for the warning about the move. Probably will keep a residual in the account rather than close it completely. Was able to buy with Alliance Trust yesterday with no problem. Like you I don't want all the eggs in too few baskets. On SPH, i think it would well go lower as the company is clearly out of favour. However, I think it is very undervalued. Exactly what it will take to see fair value and how long, is not something on which I have any clarity. | glynedwards | |
28/3/2018 16:21 | Not with Barclays. They are hopeless. Only let me buy 50k and then had to wait for another 50k then gave up for today. Will move to a better home in the new tax year. | glynedwards | |
28/3/2018 16:13 | Actually ,you can buy a quarter of a million at 19p. | steeplejack | |
28/3/2018 16:07 | Another deluded hammer, arrogant with it too, if I want your opinion on my research sources I’ll ask for it steeplejack | mercer95 | |
28/3/2018 15:41 | Oh dear what a waspish little comment... “I watched a documentary on the bbc about the Korean cosmetic market & how popular it is so the potential is definitely there,good luck.DYOR” If BBC programming is your primary source of research,I think the scantiest of knowledge might exceed your own! Anyway,enough of the trivia,Currently,you can buy on quote and deal,200,000 Sinclair at 19p....someone is dumping stock. | steeplejack | |
28/3/2018 15:29 | I’m impressed, your knowledge of West Ham far exceeds your knowledge of Sinclair Pharma, very reassuring GLA | mercer95 | |
28/3/2018 14:56 | Well,I've supported West Ham for over fifty years and the instance with poor old Mark Noble had all the looks of an unruly pitch invasion plus some nasty going ons in the stands....and on the anniversary of Bobbys demise.Theyll be no whitewash at the Queen Elizabeth stadium! | steeplejack | |
28/3/2018 14:29 | I said West Ham not Sunderland, Sinclair will bounce back, new business model, takes time, whatever has gone on before is irrelevant, same as the price today, it’s all about the trading update. | mercer95 | |
28/3/2018 13:39 | “the chart looks a bit sad, reminds me of West Ham’s season...” Oh dear,shareholders will be rioting soon then!.....and why not.I suspect that Schroders have lost patience and are getting out and in the absence of a new buyer (Tosca are up to their eyeballs and clearly don’t want to go over 29.9 per cent) the price will fall til the overhang is cleared.I suppose that the market suspects that since a new marketing partner is now not going to emerge by April Fools day,things might not be going smoothly.Could be erroneous thinking who knows.Anyway,at least i hold Shire,code SHP....Same letters as Sinclair at least! | steeplejack | |
28/3/2018 12:11 | Just topped up again let us hope announcement on partnership deal is sooner than later. | dealit | |
28/3/2018 11:28 | I spoke to soon | mercer95 | |
28/3/2018 11:01 | Looking a bit better for Sinclair today, the chart looks a bit sad, reminds me of West Ham’s season, a bit of selling recently but nothing major, a million buy trade went through last week so swings & roundabouts, only about one month to results, all looking good IMO GLA | mercer95 | |
27/3/2018 17:31 | Share markets are all about growth and expectation, with SPH putting off the partnership announcement will affected the share price IMHO. RNS Number : 5814F Sinclair Pharma PLC 22 February 2018 "Advanced discussions with potential US partners are ongoing and we expect to enter into an alternative arrangement effective from 1 April which would ensure that this highly differentiated product remains available to doctors and customers, and that we maximise its potential in the very important US market." | dealit | |
27/3/2018 13:26 | I hope you're right but when a stock slides like this,especially on AIM ,one fears the worst.If they are exceeding expectations i would be most surprised. | steeplejack |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions